LTIP829A - Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof - Google Patents

Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof

Info

Publication number
LTIP829A
LTIP829A LTIP829A LTIP829A LTIP829A LT IP829 A LTIP829 A LT IP829A LT IP829 A LTIP829 A LT IP829A LT IP829 A LTIP829 A LT IP829A LT IP829 A LTIP829 A LT IP829A
Authority
LT
Lithuania
Prior art keywords
alkyl
morpholino
propyl
amino
alkyleneimino
Prior art date
Application number
LTIP829A
Inventor
Eric Cossement
Jean Gobert
Roland Boydens
Jacques Mathieu
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of LTIP829A publication Critical patent/LTIP829A/en
Publication of LT3601B publication Critical patent/LT3601B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)

Abstract

New 2-amino-4-morpholino-6-propyl-1,3,5-triazines having the formula <IMAGE> (I) wherein R1 is hydrogen, alkyl, aralkyl or acetyl, R2 is hydroxyl, hydroxyalkyl, alkoxyalkyl, dialkylamino, arylhydroxyalkyl, (hydroxy-cycloalkyl)alkyl, alkanoyloxyalkyl, benzoyloxyalkyl, phenylacetyloxyalkyl, aminocarbonyloxyalkyl, COR3 or CONR4R5, or NR1R2=(hydroxyalkyl)alkyleneimino, R3=alkyl, aryl, haloaryl, alkylaryl, alkoxyaryl, aralkyl or aryloxy, R4=R5=hydrogen or alkyl, alkyl, alkoxy and alkanoyloxy having 1 to 4 carbon atoms, cycloalkyl and alkyleneimino having 4 to 6 carbon atoms. Moreover, when R1 is acetyl, R2 is acetoxyalkyl. Processes for the preparation thereof and pharmaceutical compositions containing the same are also given. In particular, these compounds are useful for the treatment of cognitive and behavioral disorders associated with aging and dementia syndromes, e.g. those associated with Alzheimer's disease.
LTIP829A 1988-08-16 1993-08-03 Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof LT3601B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819493A GB8819493D0 (en) 1988-08-16 1988-08-16 2-amino-4-morpholino-6-propyl-1 3 5-triazines

Publications (2)

Publication Number Publication Date
LTIP829A true LTIP829A (en) 1995-02-27
LT3601B LT3601B (en) 1995-12-27

Family

ID=10642235

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP829A LT3601B (en) 1988-08-16 1993-08-03 Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof

Country Status (28)

Country Link
US (1) US4956367A (en)
EP (1) EP0356413B1 (en)
JP (1) JPH02108675A (en)
KR (1) KR0136108B1 (en)
AT (1) ATE72241T1 (en)
AU (1) AU614247B2 (en)
CA (1) CA1317944C (en)
CY (1) CY1709A (en)
DE (1) DE68900794D1 (en)
DK (1) DK171698B1 (en)
ES (1) ES2038849T3 (en)
FI (1) FI102065B (en)
GB (1) GB8819493D0 (en)
GR (1) GR3004267T3 (en)
HK (1) HK95693A (en)
HU (1) HUT58087A (en)
IE (1) IE61205B1 (en)
IL (1) IL91243A (en)
LT (1) LT3601B (en)
MY (1) MY105008A (en)
NO (1) NO179206C (en)
NZ (1) NZ230290A (en)
PL (2) PL161161B1 (en)
PT (1) PT91438B (en)
RU (3) RU1806142C (en)
SG (1) SG27893G (en)
UA (1) UA11064A (en)
ZA (1) ZA896222B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
IT1240690B (en) * 1990-04-30 1993-12-17 Ciba Geigy Ag PIPERDIN-TRIAZIN COMPOUNDS SUITABLE FOR USE AS STABILIZERS FOR ORGANIC MATERIALS
GB9116039D0 (en) * 1991-07-25 1991-09-11 Ucb Sa Substituted cyclopropylamino-1,3,5-triazines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549755A (en) * 1968-03-27 1970-12-22 Shell Oil Co Use of 2-trichloromethyl-4-morpholinoor piperazino-6-substituted-s-triazines for inducing depressant effects in animals
JPS4969688A (en) * 1972-11-02 1974-07-05
FR2262512A1 (en) * 1974-03-01 1975-09-26 Synthelabo 2,4,6-Tri-substd. -1,3,5-triazines - with analgesic and psychotropic activity

Also Published As

Publication number Publication date
NO893279D0 (en) 1989-08-15
US4956367A (en) 1990-09-11
PL161591B1 (en) 1993-07-30
DK171698B1 (en) 1997-03-24
AU614247B2 (en) 1991-08-22
PT91438B (en) 1995-05-04
GB8819493D0 (en) 1988-09-21
NO179206B (en) 1996-05-20
PL161161B1 (en) 1993-05-31
IL91243A (en) 1995-05-26
DK398189D0 (en) 1989-08-14
PT91438A (en) 1990-03-08
NO893279L (en) 1990-02-19
MY105008A (en) 1994-07-30
IE892619L (en) 1990-02-16
JPH02108675A (en) 1990-04-20
RU1806142C (en) 1993-03-30
DK398189A (en) 1990-02-17
ZA896222B (en) 1990-05-30
ES2038849T3 (en) 1993-08-01
HK95693A (en) 1993-09-24
EP0356413B1 (en) 1992-01-29
HUT58087A (en) 1992-01-28
CA1317944C (en) 1993-05-18
RU1838312C (en) 1993-08-30
IE61205B1 (en) 1994-10-19
GR3004267T3 (en) 1993-03-31
NO179206C (en) 1996-08-28
FI893714A0 (en) 1989-08-07
SG27893G (en) 1993-06-25
EP0356413A1 (en) 1990-02-28
FI102065B1 (en) 1998-10-15
IL91243A0 (en) 1990-03-19
KR900003165A (en) 1990-03-23
AU3991789A (en) 1990-04-05
FI102065B (en) 1998-10-15
LT3601B (en) 1995-12-27
KR0136108B1 (en) 1998-04-25
CY1709A (en) 1994-01-14
ATE72241T1 (en) 1992-02-15
UA11064A (en) 1996-12-25
RU1822403C (en) 1993-06-15
NZ230290A (en) 1991-10-25
DE68900794D1 (en) 1992-03-12
FI893714A (en) 1990-02-17

Similar Documents

Publication Publication Date Title
HU896769D0 (en) Fungicide compositions comprising azolylmethylcyclopentane-benzylidene-derivatives as active ingredient and process for preparation of the active ingredients
IL91244A0 (en) Pharmaceutical compositions containing 2-amino-4-morpholino-6-propyl-1,3,5-triazines
GR3002051T3 (en) 3-oxadiazolyl and 3-carboxylic-acid beta-carboline derivatives, their preparation and their use as medicaments
LTIP829A (en) Derivatives of 2-amino-4-morpholino-6-propyl-1,3,5,-triazine and salts thereof
BR9916046A (en) Compound, pharmaceutical composition, and processes for inhibiting the replication of a herpes virus and for treating a patient suffering from a herpes virus infection
ES2032501T3 (en) A PROCEDURE FOR THE PREPARATION OF URYLENE-2,4,6-TRIAMINE-3-OXIDE DERIVATIVES.
GR3017916T3 (en) 3,4-Disubstituted phenyl-heterocycles and their use.
IL90043A0 (en) Sulfonanilides,their preparation and pharmaceutical compositions containing them
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
DE3862660D1 (en) 2,3-DIHYDRO-2-OXO-3-BENZOFURANYL ACETIC ACID DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM.
DE68922596D1 (en) 3- (3-Ethyl-1,2,4-oxadiazol-5-yl) -1-azabicycloheptane, process for its preparation and pharmaceutical preparations containing it.
ATE4384T1 (en) BENZOTHIOPYRANO(2,3-C)PYRIDINES AND THEIR ACID ADDITION SALTS, THEIR PREPARATION, THEIR USE AS MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THESE COMPOUNDS.
BG50775A1 (en) Derivatives of 2, 3- dimethyl- 1- phenyl- 4- (2- phenylmorpholinomethyl)- 5- pyrazolones and method for their preparation

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19990803